Research gives hope to Dermatitis Sufferers

Professor Mike Cork is one of the lead authors and the only UK based author of a recent paper in the New England Journal of Medicine on the treatment of severe atopic dermatitis. He and colleagues reported the successful outcome of two phase III trials using a human monoclonal antibody against interleukin-4 receptor alpha to…

Continue reading →